WindRose Health Investors backs Verified Clinical Trials
The company's secure global database is utilized by pharmaceutical sponsors, CROs, and research sites to improve participant safety and data integrity.
Takeaways
- Verified Clinical Trials is a provider of clinical trial subject registry and patient safety solutions.
- WindRose Health Investors is investing in Verified Clinical Trials.
- The business serves clinical trials, pharmaceutical sponsors, CROs.
WindRose Health Investors recapitalized Verified Clinical Trials, a provider of clinical trial subject registry solutions that detect and help prevent duplicate enrollment and protocol violations.
The company's secure global database is utilized by pharmaceutical sponsors, CROs, and research sites to improve participant safety and data integrity.
As part of the transaction, WindRose appointed Howard Miller as Chief Executive Officer, with founders Dr. Mitchell Efros and Kerri Weingard remaining actively involved.
Get Buyout Desk email updates.
Yesterday's platforms, add-ons, recaps, and exits, cleaned up on the site. Email updates are not on a fixed schedule.